PainReform Ltd. (PRFX) Social Stream



PainReform Ltd. (PRFX): $0.89

0.02 (-2.29%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

PAINREFORM LTD (PRFX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering PAINREFORM LTD.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-09-02 1 $6 $6 $6 $2.532 136.97%
2022-04-08 1 $3 $3 $3 $2.532 18.48%
2023-06-23 1 $2 $2 $2 $2.532 -21.01%
2023-07-07 1 $20 $20 $20 $2.532 689.89%
2023-10-13 1 $11 $11 $11 $2.532 334.44%
NA 1 $NA $NA $NA $2.532 NA%

Price Target Last Issued April 8, 2022

The Trend in the Analyst Price Target


Over the past 36 months, PRFX's average price target has gone up $1.

Over the past 112 days, PRFX's average upside potential has been 870.45%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-06-23 1 2 2 2 4.90 -59.18%
2023-06-23 1 2 2 2 0.49 308.16%
2023-06-23 1 20 20 20 0.49 3981.63%
2023-07-07 1 20 20 20 4.47 347.43%
2023-10-13 1 11 11 11 2.52 336.51%

PRFX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations


Over the past 122 days, PRFX's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PRFX as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, PAINREFORM LTD's number of analysts covering the stock is greater than nearly none of them.
  • In the context of all US stocks, PAINREFORM LTD's variance in analysts' estimates is lower than just about 100% of them.
  • To contextualize these metrics, consider that out of Healthcare stocks, PAINREFORM LTD's average analyst price target is greater than 66.17% of them.
  • In the context of Healthcare stocks, PAINREFORM LTD's upside potential (average analyst target price relative to current price) is higher than 256.11% of them.

Stocks similar to PAINREFORM LTD in the Pharmaceutical Products industry regarding analyst recommendations and price targets are INM, PTPI, and GRI.

Make investment decisions regarding PRFX using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!